FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
Sign Up to like & getrecommendations! Published in 2023 at "Oncoimmunology"
DOI: 10.1080/2162402x.2023.2217024
Abstract: ABSTRACT Colorectal cancer (CRC) is one of the top three malignant tumors in terms of morbidity, and the limited efficacy of existing therapies urges the discovery of potential treatment strategies. Immunotherapy gradually becomes a promising… read more here.
Keywords: crc; colorectal cancer; fxr agonist; gw4064 ... See more keywords